Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies

Journal of Oncology

Volumn 2016, Issue , 2016, Pages

  Kelly, Ciara M ^a   Shahrokni, Armin ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; HEALTH CARE INDUSTRY; HUMAN; MONITORING; ONCOLOGY; POSTMARKETING SURVEILLANCE;

EID: 84962793033     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2016/6186543     Document Type: Review

References (78)

1. T. Conroy, F. Desseigne, M. Ychou et al., "FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, " The New England Journal of Medicine, vol. 364, no. 19, pp. 1817-1825, 2011.
2. D. J. Sargent, C. H. KÖhne, H. K. Sanoffet al., "Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer, " Journal of Clinical Oncology, vol. 27, no. 12, pp. 1948-1955, 2009.
3. D. A. Karnofsky and J. H. Burchenal, "The clinical evaluation of chemotherapeutic agents in cancer, " in Evaluation of Chemotherapeutic Agents, C. M. Macleod, Ed., Columbia University Press, New York, NY, USA, 1949.
4. C. C. Schag, R. L. Heinrich, and P. A. Ganz, "Karnofsky performance status revisited: reliability, validity, and guidelines, " Journal of Clinical Oncology, vol. 2, no. 3, pp. 187-193, 1984.
5. M. M. Oken, R. H. Creech, D. C. Tormey et al., "Toxicity and response criteria of the Eastern Cooperative Oncology Group, " AmericanJournal of Clinical Oncology, vol. 5, no. 6, pp. 649-655, 1982.
6. A. E. Taylor, I. N. Olver, T. Sivanthan, M. Chi, and C. Purnell, "Observer error in grading performance status in cancer patients, " Supportive Care in Cancer, vol. 7, no. 5, pp. 332-335, 1999.
7. K. S. Albain, J. J. Crowley, M. LeBlanc, and R. B. Livingston, "Survival determinants in extensive-stage non-small-cell lung cancer: The southwest oncology group experience, " Journal of Clinical Oncology, vol. 9, no. 9, pp. 1618-1626, 1991.
8. S. P. Blagden, S. C. Charman, L. D. Sharples, L. R. A. Magee, andD. Gilligan, "Performance status score: dopatients andtheir oncologists agree?" British Journal of Cancer, vol. 89, no. 6, pp. 1022-1027, 2003.
9. C.-H. KÖhne, D. Cunningham, F. Di Costanzo et al., "Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of amultivariate analysis of 3825 patients, " Annals of Oncology, vol. 13, no. 2, pp. 308-317, 2002.
10. J. H. Schiller, D. Harrington, C. P. Belani et al., "Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer, " The New England Journal of Medicine, vol. 346, no. 2, pp. 92-98, 2002.
11. L. Sengeløv, C. Kamby, P. Geertsen, L. J. Andersen, and H. Von Der Maase, "Predictive factors of response to cisplatinbased chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer, " Cancer Chemotherapy and Pharmacology, vol. 46, no. 5, pp. 357-364, 2000.
12. D. M. Finkelstein, B. R. Cassileth, P. D. Bonomi, J. C. Ruckdeschel, E. Z. Ezdinli, and J. M. Wolter, "A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study, " American Journal of Clinical Oncology, vol. 11, no. 6, pp. 630-633, 1988.
13. J. B. Sørensen, M. Klee, T. Palshof, andH. H. Hansen, "Performance status assessment in cancer patients. An inter-observer variability study, " British Journal of Cancer, vol. 67, no. 4, pp. 773-775, 1993.
14. F. Roila, M. Lupattelli, M. Sassi et al., "Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales, " Annals of Oncology, vol. 2, no. 6, pp. 437-439, 1991.
15. E. Verger, M. Salamero, and C. Conill, "Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?" European Journal of Cancer A, vol. 28, no. 8-9, pp. 1328-1330, 1992.
16. J. Myers, K. Gardiner, K. Harris et al., "Evaluating correlation and interrater reliability for four performance scales in the palliative care setting, " Journal of Pain and Symptom Management, vol. 39, no. 2, pp. 250-258, 2010.
17. M. Ando, Y. Ando, Y. Hasegawa et al., "Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer, " British Journal of Cancer, vol. 85, no. 11, pp. 1634-1639, 2001.
18. H. J. West, "Patients with advanced non-small-cell lung cancer and marginal performance status: walking the tight rope towards improved survival, " Journal of Clinical Oncology, vol. 31, no. 23, pp. 2841-2843, 2013.
19. C. J. Langer, K. J. O'Byrne, M. A. Socinski et al., "Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-nä?ve advanced non-small cell lung cancer, " Journal of Thoracic Oncology, vol. 3, no. 6, pp. 623-630, 2008.
20. M. E. R. O'Brien, M. A. Socinski, A. Y. Popovich et al., "Randomized phase III trial comparing single-agent paclitaxel poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-nä?ve advanced non-small cell lung cancer, " Journal of Thoracic Oncology, vol. 3, no. 7, pp. 728-734, 2008.
21. D. Podsiadlo and S. Richardson, "The timed 'Up & Go': A test of basic functional mobility for frail elderly persons, " Journal of the American Geriatrics Society, vol. 39, no. 2, pp. 142-148, 1991.
22. A. B. Mitnitski, J. E. Graham, A. J. Mogilner, and K. Rockwood, "Frailty, fitness and late-life mortality in relation to chronological and biological age, " BMC Geriatrics, vol. 2, article 1, 2002.
23. J. M. Guralnik, E. M. Simonsick, L. Ferrucci et al., "A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission, " Journals of Gerontology, vol. 49, no. 2, pp. M85-M94, 1994.
24. J. C. Brown, M. O. Harhay, and M. N. Harhay, "Physical function as a prognostic biomarker among cancer survivors, " British Journal of Cancer, vol. 112, no. 1, pp. 194-198, 2015.
25. Z. H. Lewis, E. J. Lyons, J. M. Jarvis, and J. Baillargeon, "Using an electronic activity monitor system as an intervention modality: A systematic review, " BMC Public Health, vol. 15, no. 1, article 585, 2015.
26. M. Maddocks and A. Wilcock, "Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure, " Supportive Care in Cancer, vol. 20, no. 5, pp. 1113-1116, 2012.
27. M. Maddocks, A. Byrne, C. D. Johnson, R. H. Wilson, K. C. H. Fearon, and A. Wilcock, "Physical activity level as an outcome measure for use in cancer cachexia trials: A feasibility study, " Supportive Care in Cancer, vol. 18, no. 12, pp. 1539-1544, 2010.
28. M. A. Case, H. A. Burwick, K. G. Volpp, and M. S. Patel, "Accuracy of smartphone applications and wearable devices for tracking physical activity data, " The Journal of the American Medical Association, vol. 313, no. 6, pp. 625-626, 2015.
29. P. C. C. Alinia, A. Shahrokni, and H. Ghasemzadeh, Eds., A Study on Evaluating the Accuracy of Fitbit Devices on Low-Intensity Activities, Wireless Health Institute, 2015.
30. T. J. Kooiman, M. L. Dontje, S. R. Sprenger, W. P. Krijnen, C. P. van der Schans, and M. de Groot, "Reliability and validity of ten consumer activity trackers, " BMC Sports Science, Medicine and Rehabilitation, vol. 7, article 24, 2015.
31. T. Ferguson, A. V. Rowlands, T. Olds, andC. Maher, "The validity of consumer-level, activity monitors in healthy adults worn in free-living conditions: A cross-sectional study, " International Journal of Behavioral Nutrition and Physical Activity, vol. 12, article 42, 2015.
32. G. D. Fulk, S. A. Combs, K. A. Danks, C. D. Nirider, B. Raja, and D. S. Reisman, "Accuracy of 2 activitymonitors in detecting steps in people with stroke and traumatic brain injury, " Physical Therapy, vol. 94, no. 2, pp. 222-229, 2014.
33. S. M. Phillips, K. W. Dodd, J. Steeves, J. McClain, C. M. Alfano, and E. McAuley, "Physical activity and sedentary behavior in breast cancer survivors: new insight into activity patterns and potential intervention targets, " Gynecologic Oncology, vol. 138, no. 2, pp. 398-404, 2015.
34. W. A. Smith, V. G. Nolan, L. L. Robison, M. M. Hudson, and K. K. Ness, "Physical activity among cancer survivors and those with no history of cancer-a report from the National Health and Nutrition Examination Survey 2003-2006, " American Journal of Translational Research, vol. 3, no. 4, pp. 342-350, 2011.
35. R. H. Knols, E. D. de Bruin, G. Aufdemkampe, D. Uebelhart, and N. K. Aaronson, "Reliability of ambulatory walking activity in patients with hematologic malignancies, " Archives of Physical Medicine and Rehabilitation, vol. 90, no. 1, pp. 58-65, 2009.
36. R. J. E. Skipworth, G. B. Stene, M. Dahele et al., "Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring, " Clinical Nutrition, vol. 30, no. 6, pp. 812-821, 2011.
37. M. J. Mackenzie, K. E. Zuniga, L. B. Raine et al., "Associations between physical fitness indices and working memory in breast cancer survivors and age-matched controls, " Journal ofWomen's Health, vol. 25, no. 1, pp. 99-108, 2016.
38. J. K. Vallance, T. Boyle, K. S. Courneya, and B. M. Lynch, "Accelerometer-assessed physical activity and sedentary time among colon cancer survivors: Associations with psychological health outcomes, " Journal of Cancer Survivorship, vol. 9, no. 3, pp. 404-411, 2015.
39. J. K. H. Vallance, K. S. Courneya, R. C. Plotnikoff, Y. Yasui, and J. R. Mackey, "Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors, " Journal of Clinical Oncology, vol. 25, no. 17, pp. 2352-2359, 2007.
40. K. M. Mustian, L. Peppone, T. V. Darling, O. Palesh, C. E. Heckler, andG. R. Morrow, "A4-week home-based aerobic and resistance exercise program during radiation therapy: A pilot randomized clinical trial, " Journal of Supportive Oncology, vol. 7, no. 5, pp. 158-167, 2009.
41. H. B. Muss, S. Woolf, D. Berry et al., "Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer, " The Journal of the American Medical Association, vol. 293, no. 9, pp. 1073-1081, 2005.
42. H. K. Sanoff, W. R. Carpenter, T. Sturmer et al. et al., "Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years, " Journal of Clinical Oncology, vol. 30, no. 21, pp. 2624-2634, 2012.
43. D. Schrag, L. D. Cramer, P. B. Bach, and C. B. Begg, "Age and adjuvant chemotherapy use after surgery for stage III colon cancer, " Journal of the National Cancer Institute, vol. 93, no. 11, pp. 850-857, 2001.
44. A. Hurria, K. Togawa, S. G. Mohile et al., "Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study, " Journal of Clinical Oncology, vol. 29, no. 25, pp. 3457-3465, 2011.
45. M. Extermann, M. Aapro, R. Bernabei et al., "Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG), " Critical Reviews in Oncology/Hematology, vol. 55, no. 3, pp. 241-252, 2005.
46. M. Extermann and A. Hurria, "Comprehensive geriatric assessment for older patients with cancer, " Journal of Clinical Oncology, vol. 25, no. 14, pp. 1824-1831, 2007.
47. L. Repetto, L. Fratino, R. A. Audisio et al., "Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology Study, " Journal of Clinical Oncology, vol. 20, no. 2, pp. 494-502, 2002.
48. M. T. E. Puts, J. Hardt, J. Monette, V. Girre, E. Springall, and S. M. H. Alibhai, "Use of geriatric assessment for older adults in the oncology setting: A systematic review, " Journal of the National Cancer Institute, vol. 104, no. 15, pp. 1133-1163, 2012.
49. M. Extermann, "Integrating a geriatric evaluation in the clinical setting, " Seminars in Radiation Oncology, vol. 22, no. 4, pp. 272-276, 2012.
50. M. Extermann, I. Boler, R. R. Reich et al., "Predicting the risk of chemotherapy toxicity in older patients: The chemotherapy risk assessment scale for high-age patients (CRASH) score, " Cancer, vol. 118, no. 13, pp. 3377-3386, 2012.
51. S. Hoppe, M. Rainfray, M. Fonck et al., "Functional decline in older patients with cancer receiving first-line chemotherapy, " Journal of Clinical Oncology, vol. 31, no. 31, pp. 3877-3882, 2013.
52. P. Soubeyran, M. Fonck, C. Blanc-Bisson et al., "Predictors of early death risk in older patients treated with first-line chemotherapy for cancer, " Journal of Clinical Oncology, vol. 30, no. 15, pp. 1829-1834, 2012.
53. K. R. Flaherty, A.-C. Andrei, S. Murray et al., "Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test, " American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 7, pp. 803-809, 2006.
54. C. G. Cote, V. Pinto-Plata, K. Kasprzyk, L. J. Dordelly, and B. R. Celli, "The 6-min walk distance, peak oxygen uptake, and mortality in COPD, " Chest, vol. 132, no. 6, pp. 1778-1785, 2007.
55. L. W. Jones, R.-R. Cohen, S. K. Mabe et al., "Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing, " Journal of Neuro-Oncology, vol. 94, no. 1, pp. 79-85, 2009.
56. E. Ruden, D. A. Reardon, A. D. Coan et al., "Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma, " Journal of Clinical Oncology, vol. 29, no. 21, pp. 2918-2923, 2011.
57. L. W. Jones, S. M. Devlin, M. A. Maloy et al., "Prognostic importance of pretransplant functional capacity after allogeneic hematopoietic cell transplantation, " The Oncologist, vol. 20, no. 11, pp. 1290-1297, 2015.
58. H. J. Montoye, R. Washburn, S. Servais, A. Ertl, J. G. Webster, and F. J. Nagle, "Estimation of energy expenditure by a portable accelerometer, "Medicine and Science in Sports and Exercise, vol. 15, no. 5, pp. 403-407, 1983.
59. K. Y. Chen and D. R. Bassett Jr., "The technology of accelerometry-based activity monitors: current and future, " Medicine and Science in Sports and Exercise, vol. 37, no. 11, supplemen, pp. S490-S500, 2005.
60. R. P. Troiano, J. J. McClain, R. J. Brychta, and K. Y. Chen, "Evolution of accelerometer methods for physical activity research, " British Journal of Sports Medicine, vol. 48, no. 13, pp. 1019-1023, 2014.
61. CDC, "National Health and Nutrition Examination Survey 2005-2006, " November 2015, http://wwwn. cdc. gov/nchs/ nhanes/search/nhanes05 06. Aspx.
62. J.-M. Lee, Y. Kim, and G. J. Welk, "Validity of consumer-based physical activity monitors, " Medicine and Science in Sports and Exercise, vol. 46, no. 9, pp. 1840-1848, 2014.
63. R. Health, "The Future of Biosensing Wearables, " October 2015, https://rockhealth. com/reports/the-future-of-biosensingwearables/.
64. T. O'Brien, M. Troutman-Jordan, D. Hathaway, S. Armstrong, and M. Moore, "Acceptability of wristband activity trackers among community dwelling older adults, " Geriatric Nursing, vol. 36, supplement, no. 2, pp. S21-S25, 2015.
65. L. A. Cadmus-Bertram, B. H. Marcus, R. E. Patterson, B. A. Parker, and B. L. Morey, "Randomized trial of a fitbit-based physical activity intervention for women, " American Journal of Preventive Medicine, vol. 49, no. 3, pp. 414-418, 2015.
66. J. C. Michael, N. E. El Nokali, J. J. Black, and D. L. Rofey, "Mood and ambulatorymonitoring of physical activity patterns in youth with polycystic ovary syndrome, " Journal of Pediatric & Adolescent Gynecology, vol. 28, no. 5, pp. 369-372, 2015.
67. S. Langenberg, M. Schulze, M. Bartsch et al., "Physical activity is unrelated to cognitive performance in pre-bariatric surgery patients, " Journal of Psychosomatic Research, vol. 79, no. 2, pp. 165-170, 2015.
68. A. Kawagoshi, N. Kiyokawa, K. Sugawara et al., "Quantitative assessment of walking time and postural change in patients with COPD using a new triaxial accelerometer system, " International Journal of Chronic Obstructive Pulmonary Disease, vol. 8, pp. 397-404, 2013.
69. E. V. Carvalho, M. M. Reboredo, E. P. Gomes et al., "Physical activity in daily life assessed by an accelerometer in kidney transplant recipients and hemodialysis patients, " Transplantation Proceedings, vol. 46, no. 6, pp. 1713-1717, 2014.
70. J. Wielopolski, K. Reich, M. Clepce et al., "Physical activity and energy expenditure during depressive episodes of major depression, " Journal of Affective Disorders, vol. 174, pp. 310-316, 2015.
71. C. F. Fitzsimons, A. Kirk, G. Baker, F. Michie, C. Kane, and N. Mutrie, "Using an individualised consultation and activPAL feedback to reduce sedentary time in older Scottish adults: results of a feasibility and pilot study, " Preventive Medicine, vol. 57, no. 5, pp. 718-720, 2013.
72. R. Hurling, M. Catt, M. De Boni et al., "Using internet and mobile phone technology to deliver an automated physical activity program: randomized controlled trial, " Journal of Medical Internet Research, vol. 9, no. 2, article e7, 2007.
73. C. A. Pellegrini, S. D. Verba, A. D. Otto, D. L. Helsel, K. K. Davis, and J. M. Jakicic, "Thecomparison of a technology-based system and an in-person behavioral weight loss intervention, " Obesity, vol. 20, no. 2, pp. 356-363, 2012.
74. K. M. Polzien, J. M. Jakicic, D. F. Tate, and A. D. Otto, "The efficacy of a technology-based system in a short-term behavioral weight loss intervention, " Obesity, vol. 15, no. 4, pp. 825-830, 2007.
75. S. L. Shuger, V. W. Barry, X. Sui et al., "Electronic feedback in a diet-and physical activity-based lifestyle intervention for weight loss: A randomized controlled trial, " International Journal of Behavioral Nutrition and Physical Activity, vol. 8, article 41, 2011.
76. W. G. Thompson, C. L. Kuhle, G. A. Koepp, S. K. McCrady-Spitzer, and J. A. Levine, "'Go4Life' exercise counseling, accelerometer feedback, and activity levels in older people, " Archives of Gerontology and Geriatrics, vol. 58, no. 3, pp. 314-319, 2014.
77. J. G. Timmerman, M. G. Dekker-van Weering, T. M. TÖnis, H. J. Hermens, and M. M. Vollenbroek-Hutten, "Relationship between patterns of daily physical activity and fatigue in cancer survivors, " European Journal of Oncology Nursing, vol. 19, no. 2, pp. 162-168, 2015.
78. L. Liu, Y. Shi, T. Li et al., "Leisure time physical activity and cancer risk: evaluation of the WHO's recommendation based on 126 high-quality epidemiological studies, " British Journal of Sports Medicine, vol. 50, no. 6, pp. 372-378, 2016.